Addressing the accessibility and high costs of chimeric antibody receptor (CAR) T-cell and bispecific therapies is crucial ...

Janssen-Cilag International NV, a Johnson & Johnson company, today announced that the European Commission (EC) has approved an indication extension of DARZALEX® (daratumumab) subcutaneous (SC) ...

For decades, the diagnosis of multiple myeloma required evidence of end-organ damage characterized by myeloma-defining events ...

DARZALEX has significant market potential as a leading monoclonal antibody for multiple myeloma treatment. Its approval in various combinations for both newly diagnosed and relapsed/refractory ...

Pharmac, minister respond Pharmac director of pharmaceuticals Geraldine MacGibbon said it understood the significant impact of multiple myeloma and AL amyloidosis, and was speaking with ...

It is important for the nurse to assess the extent of kidney involvement in amyloidosis and the development of the nephrotic syndrome. The nephrotic syndrome is suspected when there are high ...

Nearly everyone with multiple myeloma relapses. That doesn’t make it easy. A cancer diagnosis is traumatic, especially when the cancer is treatable, but not curable. In multiple myeloma, the disease ...

Pharmac director of pharmaceuticals Geraldine MacGibbon said it understood the significant impact of multiple myeloma and AL amyloidosis, and was speaking with daratumumab supplier Janssen.

Right sural nerve and rectal biopsies confirmed amyloidosis on Congo red staining. Laboratory studies were as follows: hemoglobin, 13.3 g/dL (normal, 13.5–17.5 g/dL); normal albumin, carotene ...

Revlimid is a prescription drug used to treat certain types of blood cancers, including multiple myeloma. There are no known foods that interact with Revlimid, but there may be certain foods to ...

Xavier Leleu is Professor, Head of the Myeloma Clinic, and Head of the Department of Hematology at Centre Hospitalier Universitaire (CHU) at Université de Poitiers, France. Leleu received his medical ...